Compare Gaudium IVF with Similar Stocks
Loading Valuation Snapshot...
Stock DNA
Healthcare Services
INR 584 Cr (Micro Cap)
30.00
55
0.00%
0.27
36.63%
13.05
Revenue and Profits:
Net Sales:
25 Cr
(Quarterly Results - Dec 2025)
Net Profit:
4 Cr
Total Returns (Price + Dividend) 
Company does not have enough history
Risk Adjusted Returns v/s 
Returns Beta
Beta has not been calculated since enough price history is not available
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
19.98
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
24.53%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
14.35%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
30
Industry P/E
55
Price to Book Value
12.36
EV to EBIT
22.19
EV to EBITDA
20.59
EV to Capital Employed
9.95
EV to Sales
9.72
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
44.85%
ROE (Latest)
41.01%
Technicals key factors
Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
OBV
Shareholding Snapshot : Feb 2026
Shareholding Compare (%holding) 
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 8 FIIs (9.24%)
Promoter with highest holding
Manika Khanna (70.73%)
Highest Public shareholder
Meru Investment Fund Pcc-cell 1 (2.96%)
Individual Investors Holdings
13.52%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
14.19
22.95
-38.17%
Operating Profit (PBDIT) excl Other Income
5.83
13.28
-56.10%
Interest
1.12
0.51
119.61%
Exceptional Items
0.00
0.00
Standalone Net Profit
3.18
9.03
-64.78%
Operating Profit Margin (Excl OI)
41.09%
57.86%
-16.77%
Values in Rs Cr.
Net Sales
QoQ Growth in quarter ended Dec 2025 is -38.17% vs 64.52% in Sep 2025
Standalone Net Profit
QoQ Growth in quarter ended Dec 2025 is -64.78% vs 169.55% in Sep 2025
Annual Results Snapshot (Standalone) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
59.00
52.22
12.98%
Operating Profit (PBDIT) excl Other Income
27.86
25.07
11.13%
Interest
1.39
0.54
157.41%
Exceptional Items
0.00
0.00
Standalone Net Profit
18.63
16.64
11.96%
Operating Profit Margin (Excl OI)
47.22%
48.01%
-0.79%
Values in Rs Cr.
Net Sales
YoY Growth in year ended Mar 2025 is 12.98% vs 18.65% in Mar 2024
Standalone Net Profit
YoY Growth in year ended Mar 2025 is 11.96% vs 25.49% in Mar 2024
About Gaudium IVF and Women Health Ltd 
Gaudium IVF and Women Health Ltd
Micro Cap
Healthcare Services
No Details Available.
Company Coordinates 
No Company Details Available






